Compared to the normal brain tissues, all qPCR, western blotting, and immunohistochemistry results showed that ISL2 expression was higher in glioma tissues, and was especially increased in higher glioma WHO grades (Fig. 1h–j). Here, ISL2 is linked to central nervous system cancer.